Physician profile
Maheswari Senthil
NPI 1578721239
$32,185.77
in general payments reported to CMS, 2019-2025
6 companies · $29K in 2025
The $29K reported for 2025 was more than what 98% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.50 · 2024: $3,445 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $5,345 · Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,802.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,526.00 |
| Travel and Lodging | $5,345.06 |
| Food and Beverage | $450.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $22,071.92 | 2024-2025 | |
| On Target Laboratories, INC | $8,629.14 | 2025 | Cytalux |
| Astrazeneca Pharmaceuticals Lp | $1,074.00 | 2025 | Imfinzi |
| Medtronic, INC. | $258.96 | 2024 | Ligasure, Signia |
| Siemens Medical Solutions USA, INC. | $89.25 | 2025 | Biograph Trinion Ep Ct64 |
| Ethicon US, LLC | $62.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maheswari Senthil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.